Abstract Library
Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.
Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.
ENETS Abstract Search
Introduction: The continuous progress of comprehensive treatment enables neuroendocrine tumour liver metastasis (NENLM) that meets Milan criteria to achieve longer survival without liver transplantation (LT). LT often faces high tumour burden, while comprehensive treatment also brings new opportunities for recurrence.
Conference:
Presenting Author: Chen C
Authors: Chen C, Jiang W, Chen J, Liang Y, Xie Y,
Keywords: liver transplantation, neuroendocrine tumour liver metastasis, Milan Criteria, comprehensive treatment,
#4570 Diagnosis of carcinoid heart disease continues to be late delayed
Introduction: Carcinoid heart disease (CHD) is a serious complication of neuroendocrine tumours. It affects patients with carcinoid syndrome and results from fibrotic deposits on the heart valves. It significantly impacts patient prognosis.
Conference:
Presenting Author:
Authors: Sharma J, Shah T, Coldham C, Vickrage S, Rehman Z,
Keywords: carcinoid syndrome, neuroendocrine tumour, carcinoid heart disease, symptoms, presentation, echocardiogram, heart valves,
Introduction: Pancreatic angiosarcoma is a rare and highly aggressive tumour originated from lymphatic or vascular endothelial cells, with poor prognosis and few effective treatments. However, little is known about its tumour microenvironment and the mechanisms of its progression.
Conference:
Presenting Author: Yang Y
Authors: Yang Y, Chen L, Liu M, Lin X, Peng S,
Keywords: pancreatic angiosarcoma, single-cell RNA sequencing, immunotherapy, PD-L1, CD86,
#4521 [18F]FDG (FDG) PET/CT metrics as prognostic biomarkers in the AGITG NABNEC trial
Introduction: NABNEC was a prospective phase II trial investigating carboplatin/nab-paclitaxel in patients with advanced Grade 3 NENs (NCT02215447).
Conference:
Presenting Author: Kong G
Authors: Kong G, Ayati N, Brown C, Siu D, Mak W,
Keywords: Prognostic marker, prospective trial, chemotherapy, PET imaging, FDG, metabolic tumour volume, suv,
Introduction: Grade I neuroendocrine tumours (NETs) represent a distinct clinico-histological entity that requires a tailored management approach. The treatment of these tumours has evolved, but challenges remain, especially in regions with limited access to nuclear medicine imaging.
Conference:
Presenting Author:
Authors: Boudersa A, Kouadri N, Bouguettaya A,